DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nexavar (Sorafenib) - News

 
 



News related to Nexavar (Sorafenib) and/or conditions it is approved for

More Than Okay to Reduce Sorafenib Dose for Liver Cancer
Source: Medscape Hematology-Oncology Headlines [2017.09.15]
Initially reducing the dosage of the oral therapy did not compromise overall survival in hepatocellular carcinoma and had important benefits.
Medscape Medical News

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017